<DOC>
	<DOCNO>NCT01974674</DOCNO>
	<brief_summary>It multicentre , sequential , phase II clinical trial , aim evaluate allogeneic islet transplantation treatment type 1 diabetes . 19 patient type 1 diabetes include ideally distribute evenly : patient unstable diabetes without renal insufficiency ( AI group `` islet alone '' international customary determination ) patient function kidney transplant ( IAK group `` islet kidney '' ) . The main endpoint define restoration normal glycemic control without insulin 6 month graft .</brief_summary>
	<brief_title>Allogeneic Islet Transplantation Treatment Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patients type 1 diabetes 18 &lt; Age &lt; 55 year Plasma Cpeptide &lt; 0.2 ng/ml basal stimulate glucagon Evolution diabetes 5 year Regular patient followup ( &gt; equal 2 visit per year diabetologist ) Patient receive information give consent write Absence HIV , hepatitis B hepatitis C , HTLV12 ABO compatibility donor Cross match negative AntiHLA antibody ( class I / class II ) detect lymphocytotoxicity &lt; 20 % PCR negative BK virus blood ( amplify BK virus replication ATG ) . Accepting patient effective contraception study period For patient group IA Glomerular filtration rate estimate MDRD &gt; 50 ml/min/1.73m2 No perception hypoglycaemia ( le 0.54 mg/dl glucose ) least one value document two year precede and/or Occurrence least one severe hypoglycemic episode ( third require ) unexplained two year and/or least two episode ketoacidosis per year Average HbA1c &gt; 8.5 % two year , despite intensified treatment ( basal pattern , bolus ) â€¢ For patient IAK functional renal graft least 1 year glomerular filtration rate &gt; 50 ml/min/1.73 m2 proteinuria &lt; 0.5 g/day Absence acute rejection renal previous 6 month BMI &gt; 28 Need insulin &gt; 1 U/kg per day Pregnancy , lactation Intention childbearing two sex Psychiatric Disorders Inability communicate cooperate investigator Lack therapeutic compliance , include HbA1C &gt; 12 % Chronic liver disease Progressive heart disease myocardial infarction within 6 month prior inclusion , unbalanced CHD ) Proliferative retinopathy unstabilized History cancer , whatever date , except basal squamous cell skin cancer 1 year . Systemic infection Chronic high risk require corticosteroid Need longterm corticosteroid , outside specify renal transplantation , patient wean transplantation Anticoagulant vitamin K antiplatelet treatment Disorders hemostasis TP &lt; 60 % TCA &gt; 1.5 time control AntiHLA antibody ( class I and/or class II ) detect lymphocytotoxicity &gt; 20 % Platelets &lt; 100 giga/L and/or neutrophil &lt; 1.5 giga/L Chronic intoxication alcohol , tobacco , substance ( abstinence &gt; 6 month require ) Active infection hepatitis B , hepatitis C HIV , HTLV1HTLV2 Ascites</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>diabetes</keyword>
	<keyword>transplantation</keyword>
</DOC>